Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
Cyclacel Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Cyclacel Pharmaceuticals reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Cyclacel Pharmaceuticals received on average a compensation package of $561K, a 41% decrease compared to previous year.
Average pay of disclosed executives at Cyclacel Pharmaceuticals
Spiro Rombotis, Chief Executive Officer, received $764K in total, which decreased by 43% compared to 2021. 72% of Rombotis' compensation, or $546K, was in salary. Rombotis also received $169K in bonus and $48K in other compensation.
Mark Kirschbaum, Chief Medical Officer, received a compensation package of $524K, which decreased by 34% compared to previous year. 73% of the compensation package, or $382K, was in salary.
Paul McBarron, Chief Financial Officer, earned $395K in 2022, a 44% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.